Cargando…
Daily Vaginal Application of Dienogest (Visanne©) for 3 Months in Symptomatic Deeply Infiltrating Rectovaginal Endometriosis: A Possible New Treatment Approach?
A 27-year-old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well. The patient reported less side effects compared to the oral use of dienogest. After 3 months of dienogest treatment, th...
Autor principal: | Ebert, Andreas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971254/ https://www.ncbi.nlm.nih.gov/pubmed/29862105 http://dx.doi.org/10.1155/2018/8175870 |
Ejemplares similares
-
Uterine rupture following laparoscopic excision of deeply invasive rectovaginal endometriosis: Is it the song or the singer?
por: Nezhat, Ceana, et al.
Publicado: (2020) -
Delivery after Operation for Deeply Infiltrating Endometriosis
por: Allerstorfer, Christina, et al.
Publicado: (2016) -
Dienogest and the Risk of Reoperation in Endometriosis
por: Seo, Yong-Soo, et al.
Publicado: (2021) -
Safe multidisciplinary approach in deeply infiltrating endometriosis (DIE): is it feasible?
por: de Ávila, Ivete, et al.
Publicado: (2014) -
Dienogest in long-term treatment of endometriosis
por: Schindler, Adolf E
Publicado: (2011)